title: [Clinical laboratory approach to evaluate administration dose of arbekacin. Reevaluation of in vitro MIC break points in the disk susceptibility test].
abstract: Antimicrobial activities of arbekacin (ABK) against various clinical isolates, 335 strains obtained in 1991, were determined and the reliability of the ABK disk susceptibility test in estimating approximate values of MICs was studied. In addition, clinical significance of two different systems for the interpretation of the disk tests was evaluated as to which system would be more useful for the evaluation of clinical efficacy of ABK. The 4 category system used in Japan, and the system proposed by the Japanese Society for Antimicrobial Chemotherapy were studied. In this study, MICs were determined using the Mueller-Hinton agar containing 50 mg/L of Ca and 25 mg/L of Mg at an inoculum level of 10(6) CFU/ml. MIC90 values of ABK against Staphylococcus aureus (MSSA and MRSA) and Staphylococcus epidermidis were both 3.13 micrograms/ml. Those against Escherichia coli, Klebsiella pneumoniae, Proteus mirabilis and Proteus vulgaris, Enterobacter spp., and Citrobacter spp., were also < or = 3.13 micrograms/ml. MIC90 values against Pseudomonas aeruginosa and Serratia spp. were both 50 micrograms/ml. The disk susceptibility test was carried out according to the instruction in the Showa disk manual. The inhibition zones obtained with the disk method were compared with MICs. Results of ABK disk susceptibility test with 30, 10, 5 or 2 micrograms disks were well correlated with MICs, showing the reliability of the disk method in estimating approximate values of MICs (r = -0.627 approximately -0.724, P < 0.01). In the 4 category classification system currently used, break points in MIC values of ABK proposed are (+ + +) MIC < 3 micrograms/ml, (++) MIC > 3-10 micrograms/ml, (+) MIC > 10-50 micrograms/ml and (-) MIC > 50 micrograms/ml. The results obtained with Showa 30 micrograms disks showed false positive in 13.4%, and false negative in 3.9% of the samples. With 10 micrograms disks, false positive and false negative were 8.1%, and 3.9%, respectively. Similarly, those with 5 micrograms and 2 micrograms disks were 6.9% and 7.2%, and 3.0% and 14.6%, respectively. In the break point classification system of Japanese Society for Antimicrobial Chemotherapy, the MIC break point for ABK proposed is 2 micrograms/ml. It appeared to be difficult to make out this break point on the inhibition zone diameters obtained with various disks used, since there were no significant difference in the inhibition zone diameters against strains with MIC values ranging 0.39-3.13 micrograms/ml. A pharmacokinetic examination with the recommended dose schedule for ABK (100 mg i.m. or i.v.) showed that plasma levels of ABK reached 3.7-11.3 micrograms/ml.(ABSTRACT TRUNCATED AT 400 WORDS)
authors.affiliation: Department of Clinical Investigation, Kitano Hospital, Tazuke Kofukai Medical Research Institute.
authors.forename: K
authors.initials: K
authors.lastname: Matsuo
authors.forename: T
authors.initials: T
authors.lastname: Uete
mesh_terms: D000617:Aminoglycosides; D000900:Anti-Bacterial Agents; D001419:Bacteria / Q000187:drug effects; D003982:Dibekacin / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000493:pharmacokinetics / Q000494:pharmacology; D005188:False Negative Reactions; D005189:False Positive Reactions; D006801:Humans; D008826:Microbial Sensitivity Tests / Q000379:methods
chemical_list: D000617:Aminoglycosides; D000900:Anti-Bacterial Agents; D003982:Dibekacin; C031986:arbekacin